Several New Medicines July 3, 1996

Several New Medicines July 3, 1996

<!-- translated-chunk:29/63 -->

1. Bromocyclamine ethanol: This product is a mucolytic agent with a significant airway-clearing effect. Adults may take 30 mg three times daily by mouth; for the syrup form, 5 mL is equivalent to 30 mg.

2. Suprastin: This medication is cefoperazone combined with a β-lactamase inhibitor. It has now been discovered that many pathogenic bacteria commonly produce a β-lactamase enzyme. Due to the production of this active enzyme, bacteria have developed antibiotic resistance. To address this resistance, a β-lactamase inhibitor was developed. Currently, the β-lactamase inhibitor found is sulbactam. The combination of this agent with cefoperazone forms "Suprastin." The usual dosage is 2–4 g, diluted in 250 mL of normal saline for intravenous drip.

3. Trade names of several new antibiotics: Cefotaxime—Kefulon; Ceftriaxone—Rocefin; Cefradine—Fudaxin; Imipenem/cilastatin sodium—Tienam. The dosage for all of the above antibiotics is 2–4 g per day, with Kefulon and Fudaxin having a higher dosage of 4–6 g.

4. Cefaclor capsules: Also known as cefaclor benzyl, adults take 0.25 g three times daily by mouth, with a maximum daily dose not exceeding 4 g.